DESTRUCTION-RESISTANT DOSAGE FORM CONTAINING ANIONIC POLYMER Russian patent published in 2017 - IPC A61K9/16 A61K9/20 A61K31/00 A61K47/30 

Abstract RU 2607499 C2

FIELD: pharmaceutics.

SUBSTANCE: invention relates to pharmaceutics, namely to dosage form in form of tablets with tensile strength of at least 500 N containing pharmacologically active component (A) selected from hydrocodone, hydromorphone, morphine, oxycodone, oxymorphone, tramadol and their pharmaceutically acceptable salts; polymer (B) selected from (i) homopolymer of acrylic acid, cross-linked allyl sucrose or allyl pentaerythritol, or (ii) copolymer of acrylic acid and C10-C30-alkyl-acrylate, cross-linked allyl pentaerythritol, or (iii) interpolymer selected from homopolymers of acrylic acid, cross-linked allyl sucrose or allyl pentaerythritol, and copolymers of acrylic acid and C10-C30-alkyl-acrylate, cross-linked allyl pentaerythritol containing copolymer block of polyethylene glycol and ester of C8-C30-alkyl acid; and from 30 to 90 wt% of polyethylene oxide (C) with average molecular weight from 2,500,000 to 15,000,000 g/mol, wherein component (A) is present in controlled-release matrix containing polymer (B) and polyethylene oxide (C).

EFFECT: invention provides production of destruction-resistant dosage forms with prolonged release of active component.

5 cl, 8 ex, 19 tbl, 16 dwg

Similar patents RU2607499C2

Title Year Author Number
DESTRUCTION-RESISTANT DOSAGE FORM CONTAINING AN INORGANIC SALT 2011
  • Barnshajd Lutts
RU2604676C2
OXIDATION STABLE AND BREAKING RESISTANCE DOSAGE FORM 2010
  • Lutts Barnshajd
  • Ehrik Galija
  • Zebastian Shvir
  • Ul'Rike Bertram
  • Anja Gajssler
  • Kornelija Grissmann
  • Iogannes Bartolomehus
RU2567723C2
PHARMACEUTICAL COMPOSITION 2011
  • Malkhotra Dzhina
  • Purandare Dr. Shrinivas Madkhukar
RU2589842C2
DRUG FORM 2009
  • Jan Ehzhen Mari Zhozef
  • Keken Filip Rene Irena
  • Vorspuls Zhodi Firmin Marseline
  • Fore Anne
  • Arkenau-Marik Ehlizabet
  • Barnshajd Lutts
  • Bartolomojs Iogannes
  • Frevel' Mark
  • Galia Ehrik
  • Tsigler Iris
  • Shjussele Andrea
RU2493830C2
MISUSE PROTECTED DOSAGE FORM FOR OXIDATION SENSITIVE OPIOIDS 2010
  • Iogannes Bartolomehus
  • Anja Gajssler
  • Ul'Rike Bertram
  • Kornelija Grissmann
RU2555531C2
LAYERS FOR MECHANICAL PROTECTION OF SOLID DOSAGE FORMS 2008
  • Soler Ransani Luis
  • Kasadeval' Pukhals Khemma
RU2500389C2
PHARMACEUTICAL COMPOSITION OF OMEPRAZOL 2012
  • Sangra Peres Khaume
  • Alkoser Aransana Kristina
RU2647472C2
PERORAL DABIGATRAN ETEXILATE PHARMACEUTICAL COMPOSITIONS 2013
  • Pilgaonkar Pratibkha S.
  • Rustomdzhee Makharuk T.
  • Gandkhi Anilkumar S.
RU2633482C2
PHARMACEUTICAL COMPOSITIONS OF ACOTIAMIDE AND PROTON PUMP INHIBITOR 2019
  • Kanagasabapathy, Yuvaneshwari
  • Venugopal, Hariharan
  • Ayachi, Nidhish
  • Gangwal, Rahul Prakash
  • Maharana, Rajib Lochan
  • Raut, Prashant Popatrao
  • Srivastava, Saurabh
  • Choudhury, Anup Avijit
  • Raghuvanshi, Rajeev
RU2820820C2
PHARMACEUTICAL COMPOSITION CONTAINING BENZOCAINE WITH ENHANCED STABILITY 2018
  • Ammer, Dr. Dr. Richard
  • Buss, Dr. Uwe
RU2761828C2

RU 2 607 499 C2

Authors

Barnshajd Lutts Dr.

Shvir Zebastian Dr.

Bartolomojs Iogannes Dr.

Dates

2017-01-10Published

2011-09-01Filed